March 9 (Reuters) - GSK said on Monday it will receive up to $690 million from Italian pharmaceutical company Alfasigma for ...

Italian pharma Alfasigma is handing $300 million to GSK for an itching treatment the FDA coul | Italian pharma Alfasigma is handing $300 million to GSK for an itching treatment the FDA could approve ...

GSK’s linerixibat is currently under regulatory review in the US, Europe, and China, amongst other regions.

The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader ...

GSK plc GSK signed a license agreement with Italy-based Alfasigma. Per the terms of the agreement, Alfasigma has acquired exclusive global rights from GSK to develop and market linerixibat, an ...

Persistent itching, yellowing eyes, spider angiomas, or frequent bruising can indicate liver dysfunction. Early diagnosis improves outcomes.

GSK has signed an eleventh-hour agreement to give Alfasigma rights to its primary biliary cholangitis (PBC) therapy ...

Obeticholic acid, which is marketed as Ocaliva as a treatment for a type of liver disease known as primary biliary cholangitis, has come under scrutiny recently. Although the US Food and Drug ...

The sudden need to itch her palms and soles of her feet that hit Jayne Pilkington one night was so maddening she scratched them until they bled. ‘It felt like something was crawling deep in my veins ...

Content developed independently by our editors and supported by our partners. You may only associate your liver with breaking down alcohol, but this organ—the largest in the body—plays a role in more ...

Cirrhosis can cause scar tissue to gradually replace healthy liver cells. In time, this can affect liver function and lead to hair, skin, and nail symptoms such as rashes and discoloration. Cirrhosis ...